Home
Resources
Publications
Increased Hepatic Synthesis and Dysregulation of Cholesterol Metabolism Is Associated With the Severity of Nonalcoholic Fatty Liver Disease

Increased Hepatic Synthesis and Dysregulation of Cholesterol Metabolism Is Associated With the Severity of Nonalcoholic Fatty Liver Disease

Hae-Ki Min, Ashwani Kapoor, Michael Fuchs, Faridoddin Mirshahi, Huiping Zhou, James Maher, John Kellum, Russell Warnick, Melissa J Contos, Arun J Sanyal

Cell Metab. 2012 May 2;15(5):665-74.

PMID: 22560219

Abstract:

Nonalcoholic fatty liver disease (NAFLD) is associated with increased cardiovascular and liver-related mortality. NAFLD is characterized by both triglyceride and free cholesterol (FC) accumulation without a corresponding increment in cholesterol esters. The aim of this study was to evaluate the expression of cholesterol metabolic genes in NAFLD and relate these to disease phenotype. NAFLD was associated with increased SREBP-2 maturation, HMG CoA reductase (HMGCR) expression and decreased phosphorylation of HMGCR. Cholesterol synthesis was increased as measured by the circulating desmosterol:cholesterol ratio. miR-34a, a microRNA increased in NAFLD, inhibited sirtuin-1 with downstream dephosphorylation of AMP kinase and HMGCR. Cholesterol ester hydrolase was increased while ACAT-2 remained unchanged. LDL receptor expression was significantly decreased and similar in NAFLD subjects on or off statins. HMGCR expression was correlated with FC, histologic severity of NAFLD and LDL-cholesterol. These data demonstrate dysregulated cholesterol metabolism in NAFLD which may contribute to disease severity and cardiovascular risks.

Chemicals Related in the Paper:

Catalog Number	Product Name	Structure	CAS Number	Price
AP313042	Desmosterol		313-04-2	Price

As a specialist in analytical chemical Products, Alfa Chemistry offers consumers a wealth of raw materials and a full range of technologies and services.

QUICK LINKS

HEADQUARTERS

Tel:

Fax:

Email: